JNJ vs UNH
Johnson & Johnson vs UnitedHealth Group Incorporated · Updated Nov 13, 2026
JNJ — 15 winsUNH — 8 wins
Price Performance
JNJ +46.63%UNH +22.38%
Performance
| JNJ | UNH | |
|---|---|---|
| 1 Month | +11.92% | +2.45% |
| 3 Months | +9.15% | +0.89% |
| 6 Months | +23.13% | +1.56% |
| YTD | +37.32% | +22.78% |
| 1 Year | +46.61% | +26.04% |
| 3 Year | +75.85% | -20.22% |
| 5 Year | +75.43% | +23.70% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +38.1% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| UNH | +21.0% | -35.6% | -6.2% | +1.5% | +5.5% | +43.7% | +19.9% | +20.7% | +12.6% | +36.5% | +37.4% | +16.7% |
Valuation
| JNJ | UNH | |
|---|---|---|
| P/E Ratio | 32.85 | 30.61 |
| Forward P/E | 11.17 | 9.99 |
| PEG Ratio | 2.75 | 2.08 |
| P/S Ratio | 7.01 | 0.80 |
| P/B Ratio | 8.31 | 3.48 |
| EV/EBITDA | 21.22 | 17.88 |
Financials
| JNJ | UNH | |
|---|---|---|
| EPS (TTM) | $8.65 | $13.24 |
| Gross Margin | +71.49% | +22.74% |
| Operating Margin | +26.58% | +8.05% |
| Net Margin | +21.76% | +5.62% |
| ROE | +25.92% | +11.59% |
| ROA | +10.47% | +3.85% |
| Debt/Equity | 0.22 | 0.75 |
Growth
| JNJ | UNH | |
|---|---|---|
| Revenue Growth YoY | +9.91% | +1.96% |
| Revenue Growth QoQ | -2.04% | -1.32% |
| EPS Growth YoY | -52.86% | +0.73% |
| EPS Growth QoQ | +1.90% | +62627.30% |
Technical
| JNJ | UNH | |
|---|---|---|
| RSI (14) | 64.54 | 57.72 |
| % From 20-Day SMA | +5.24% | -0.52% |
| % From 50-Day SMA | +6.55% | +3.58% |
| % From 200-Day SMA | +13.90% | +10.76% |
| % From 52-Week High | -0.66% | -12.20% |
| % From 52-Week Low | +47.19% | +58.34% |
Analyst Ratings
JNJ
Buy(24 analysts)
Strong SellHoldStrong Buy
Price Target
$285.31
+3.75% upside
UNH
Buy(39 analysts)
Strong SellHoldStrong Buy
Price Target
$478.68
+21.62% upside
Overview
| JNJ | UNH | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Healthcare Plans |
| Exchange | NYSE | NYSE |
| Market Cap | $675.03B | $361.04B |
| Shares Outstanding | 2.41B | 897.6M |
| Avg Volume (10D) | 7.93M | 5.35M |
| Dividend Yield | 1.88% | 2.25% |
Frequently Asked Questions
Is JNJ or UNH a better buy right now?
Based on 23 comparable metrics, JNJ leads in 15 categories while UNH leads in 8. JNJ has a consensus analyst rating with 24 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or UNH?
Over the past year, JNJ returned +46.61% compared to UNH's +26.04%. In the short term (1 month), JNJ returned +11.92% vs UNH's +2.45%.
Is JNJ or UNH more expensive?
JNJ trades at a P/E of 32.85 compared to UNH's 30.61. On a price-to-sales basis, JNJ trades at 7.01x vs UNH's 0.80x. Forward P/E: JNJ at 11.17 vs UNH at 9.99.
Which stock has higher growth, JNJ or UNH?
JNJ's revenue grew +9.91% year-over-year compared to UNH's +1.96%. EPS growth: JNJ at -52.86% vs UNH at +0.73%.
Do JNJ and UNH pay dividends?
JNJ pays a dividend with a yield of 1.88%. UNH pays a dividend with a yield of 2.25%.
Which stock do analysts prefer, JNJ or UNH?
JNJ has 24 analysts with a target price of $285.31 (+3.75% upside). UNH has 39 analysts with a target of $478.68 (+21.62% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.